Expertise in
17
conditions

Dr. Dominick J. Angiolillo

Internal Medicine
Uf Health Cardiovascular Center-North
15255 Max Leggett Pkwy Ste 3600, 
Jacksonville, FL 
Accepting New Patients
Expertise in
17
conditions
Uf Health Cardiovascular Center-North
15255 Max Leggett Pkwy Ste 3600, 
Jacksonville, FL 

Overview

Dominick Angiolillo is a primary care provider, practicing in Internal Medicine in Jacksonville, Florida.

Dr. Angiolillo is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Acute Coronary Syndrome, Heart Attack, Percutaneous Coronary Intervention (PCI), and Stent Placement.

He is actively involved in clinical research, co-authoring 653 peer reviewed articles and participating in 18 clinical trials. Dr. Angiolillo is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in FL

Hospital Affiliations

Flagler Hospital
Southeast Georgia Health System -- Camden Campus
Shands Jacksonville

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Uf Health Cardiovascular Center-North
15255 Max Leggett Pkwy Ste 3600, Jacksonville, FL 32218
Other Locations
Uf Health Cardiovascular Center-Jacksonville
655 W 8th St # 5, Jacksonville, FL 32209

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

18 Clinical Trials

Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After Undergoing Percutaneous Coronary Intervention:The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) - 2 Study
Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After Undergoing Percutaneous Coronary Intervention:The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) - 2 Study
Enrollment Status: Completed
Publish Date: July 31, 2025
Intervention Type: Drug
Study Drugs: Ticagrelor, Clopidogrel
Study Phase: Phase 4
Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry
Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry
Enrollment Status: Active_not_recruiting
Publish Date: June 13, 2025
Pharmacodynamic Effects of Different Ticagrelor Maintenance Dosing Regimens With and Without Aspirin in Patients With Diabetes Mellitus: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-7 Study
Pharmacodynamic Effects of Different Ticagrelor Maintenance Dosing Regimens With and Without Aspirin in Patients With Diabetes Mellitus: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-7 Study
Enrollment Status: Completed
Publish Date: March 30, 2025
Intervention Type: Drug
Study Drugs: Ticagrelor, Aspirin, Clopidogrel
Study Phase: Phase 4
Switching From Standard of Care Dual Antiplatelet Treatment (DAPT) Regimens With Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition (DPI) With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study
Switching From Standard of Care Dual Antiplatelet Treatment (DAPT) Regimens With Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition (DPI) With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study
Enrollment Status: Completed
Publish Date: April 26, 2023
Intervention Type: Drug
Study Drugs: Clopidogrel, Prasugrel, Ticagrelor, Aspirin, Rivaroxaban
Study Phase: Phase 4
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Enrollment Status: Unknown
Publish Date: February 16, 2023
Intervention Type: Drug, Device
Study Phase: Phase 3
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Drugs: Ticagrelor, Prasugrel
Study Phase: Phase 4
Pharmacodynamic Effects of Low-dose Rivaroxaban in Combination With Antiplatelet Therapies in Patients With Coronary and Peripheral Artery Disease Manifestations
Pharmacodynamic Effects of Low-dose Rivaroxaban in Combination With Antiplatelet Therapies in Patients With Coronary and Peripheral Artery Disease Manifestations
Enrollment Status: Completed
Publish Date: June 27, 2022
Intervention Type: Drug
Study Phase: Phase 4
Implementation of CYP2C19 Genotyping to Guide Antiplatelet Therapy for Patients Undergoing Cardiac Catheterization at UF Health Jacksonville
Implementation of CYP2C19 Genotyping to Guide Antiplatelet Therapy for Patients Undergoing Cardiac Catheterization at UF Health Jacksonville
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Device
Impact of the PCSK9 Inhibitor Evolocumab on the Pharmacodynamic Effects of Clopidogrel in Patients With Atherosclerotic Cardiovascular Disease and High On-Treatment Platelet Reactivity
Impact of the PCSK9 Inhibitor Evolocumab on the Pharmacodynamic Effects of Clopidogrel in Patients With Atherosclerotic Cardiovascular Disease and High On-Treatment Platelet Reactivity
Enrollment Status: Completed
Publish Date: February 17, 2022
Intervention Type: Other, Drug
Study Phase: Phase 4
A Randomized Comparison of Platelet Inhibition Using a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Prior Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-6 Study
A Randomized Comparison of Platelet Inhibition Using a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Prior Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-6 Study
Enrollment Status: Completed
Publish Date: November 30, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 9 Less Clinical Trials

653 Total Publications

Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.
Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.
Journal: The New England journal of medicine
Published: August 31, 2026
Similar Doctors
Expertise in
13
conditions
Dr. Ron Schey
Internal Medicine
Expertise in
13
conditions
Dr. Ron Schey
Internal Medicine

University Of Florida Jacksonville Physicians Inc

76011 William Burgess Blvd, 
Yulee, FL 
 (9.4 miles away)
904-633-0797
Languages Spoken:
English
See accepted insurances

Ron Schey is a primary care provider, practicing in Internal Medicine in Yulee, Florida. Dr. Schey is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Gastroparesis, Small Bowel Bacterial Overgrowth, Gastroesophageal Reflux Disease (GERD), Endoscopy, and Colonoscopy.

Expertise in
6
conditions
Dr. Stephanie S. Faubion
Internal Medicine
Expertise in
6
conditions
Dr. Stephanie S. Faubion
Internal Medicine

Mayo Clinic Hospital In Florida

4500 San Pablo Rd S, 
Jacksonville, FL 
 (20.5 miles away)
904-953-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Stephanie Faubion is a primary care provider, practicing in Internal Medicine in Jacksonville, Florida. Dr. Faubion is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Menopause, Amenorrhea, Premature Ovarian Failure, Hormone Replacement Therapy (HRT), and Reconstructive Urology Surgery. Dr. Faubion is currently accepting new patients.

Expertise in
8
conditions
Dr. Chrisandra L. Shufelt
Internal Medicine
Expertise in
8
conditions
Dr. Chrisandra L. Shufelt
Internal Medicine

Mayo Clinic Hospital In Florida

4500 San Pablo Rd S, 
Jacksonville, FL 
 (20.5 miles away)
904-953-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Chrisandra Shufelt is a primary care provider, practicing in Internal Medicine in Jacksonville, Florida. Dr. Shufelt is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Menopause, Coronary Heart Disease, Amenorrhea, Heart Failure with Preserved Ejection Fraction (HFpEF), and Hormone Replacement Therapy (HRT). Dr. Shufelt is currently accepting new patients.

Frequently Asked Questions about Dr. Dominick J. Angiolillo

How do I make an appointment with Dr. Dominick J. Angiolillo?

You can book an appointment with Dr. Dominick J. Angiolillo by calling their office at 904-383-1011. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Dominick J. Angiolillo a top-rated expert for Percutaneous Coronary Intervention (PCI)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Dominick J. Angiolillo is classified as an Elite expert for Percutaneous Coronary Intervention (PCI), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Dominick J. Angiolillo specialize in?

While Dr. Dominick J. Angiolillo is a Internal Medicine, they have specific expertise in Percutaneous Coronary Intervention (PCI), Coronary Heart Disease, and Acute Coronary Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Dominick J. Angiolillo participate in research or clinical trials?

Yes. Dr. Dominick J. Angiolillo has published 653 articles and abstracts on conditions like Percutaneous Coronary Intervention (PCI). You can view a list of Dr. Dominick J. Angiolillo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Dominick J. Angiolillo accept my insurance?

Dr. Dominick J. Angiolillo accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 904-383-1011 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Angiolillo's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 45 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile